Return to FDA Consumer Articles
Purchasing Pet Drugs Online: Buyer Beware (video)
Consumers should be cautious when buying pet drugs online and should not let Internet pharmacies evaluate their pets.
FDA MedWatch Alertson Drugs.com
- Compounded Prescription Therapies By Pentec Health Inc.: Recall - Lack Of Sterility AssuranceMay 17, 2013
Pentec Health, Inc. initiated a limited, voluntary recall of in-date nutritional prescriptions for renal patients due to lack of sterility assurance...
- Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended DosesMay 14, 2013
Including Ambien, Ambien CR, Edluar, and Zolpimist [UPDATE 05/14/2013] Today, the U.S. Food and Drug Administration (FDA) is notifying the public...
- Atriphen dietary supplement (Xymogen brand): Recall - Potential Allergic Reaction Due to Milk and SoyMay 9, 2013
The nutraceutical company, Xymogen, (Orlando, FL) and FDA, is notifying consumers and health professionals of the recall of Atriphen, a product sold...
- SexVoltz, Velextra, and Amerect by Beomonstar Products: Recall - Undeclared Drug IngredientMay 8, 2013
BeaMonstar Products notified the public that it is recalling its SexVoltz, Velextra, and Amerect capsules to the retail level. Laboratory analysis...
- The Compounding Shop: FDA News Release - Lack of Sterility Assurance of Drug ProductsMay 8, 2013
The U.S. Food and Drug Administration is alerting health care providers, hospital supply managers, and pharmacists that the FDA’s preliminary...
- Lightning Rod Capsules: Recall - Undeclared Drug IngredientMay 7, 2013
Chang Kwung announced today that it is conducting a voluntary nationwide recall of the company’s dietary supplements sold under the brand name...
- Bullet Proof: Public Notification - Undeclared Drug IngredientMay 7, 2013
FDA is advising consumers not to purchase or use “Bullet Proof,” a product promoted and sold for sexual enhancement on various websites and in...
- Kadcyla (ado-trastuzumab emtansine): Drug Safety Communication - Potential Medication Errors Resulting from Name ConfusionMay 6, 2013
The FDA notified health care professionals that the use of the incorrect nonproprietary name for the breast cancer drug Kadcyla (ado-trastuzumab...
- Valproate Anti-Seizure Products: Drug Safety Communication - Contraindicated for Pregnant Women for Prevention of Migraine HeadachesMay 6, 2013
Including valproate sodium (Depacon), divalproex sodium (Depakote, Depakote CP, and Depakote ER), valproic acid (Depakene and Stavzor), and their...
- American Lifestyle Vicerex and Black Ant Capsules: Recall - Undeclared Drug IngredientMay 2, 2013
May 1, 2013 - American Lifestyle is announcing that it is conducting a voluntary recall of all lots of Vicerex UPC 893490820087 and Black Ant UPC...
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated Apr 24th, 2013), Cerner Multum™ (updated Apr 19th, 2013), Wolters Kluwer™ (updated Apr 30th, 2013) and others. To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2013 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here